James H Stanker - Net Worth and Insider Trading
James H Stanker Net Worth
The estimated net worth of James H Stanker is at least $1,954 dollars as of 2024-11-13. James H Stanker is the CFO of Processa Pharmaceuticals Inc and owns about 1,826 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $1,954. Details can be seen in James H Stanker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James H Stanker has not made any transactions after 2021-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James H Stanker
James H Stanker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James H Stanker owns 2 companies in total, including Processa Pharmaceuticals Inc (PCSA) , and GSE Systems Inc (GVP) .
Click here to see the complete history of James H Stanker’s form 4 insider trades.
Insider Ownership Summary of James H Stanker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2023-10-10 | Chief Financial Officer |
| GVP | GSE Systems Inc | 2016-08-08 | director |
James H Stanker Latest Holdings Summary
James H Stanker currently owns a total of 1 stock. James H Stanker owns 1,826 shares of Processa Pharmaceuticals Inc (PCSA) as of June 21, 2021, with a value of $1,954.
Latest Holdings of James H Stanker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2021-06-21 | 1,826 | 1.07 | 1,954 |
Holding Weightings of James H Stanker
James H Stanker Form 4 Trading Tracker
According to the SEC Form 4 filings, James H Stanker has made a total of 3 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Processa Pharmaceuticals Inc is the acquisition of 50 shares on June 21, 2021, which cost James H Stanker around $6,810.
Insider Trading History of James H Stanker
- 1
James H Stanker Trading Performance
GuruFocus tracks the stock performance after each of James H Stanker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James H Stanker is 6.5%. GuruFocus also compares James H Stanker's trading performance to market benchmark return within the same time period. The performance of stocks bought by James H Stanker within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James H Stanker's insider trading performs compared to the benchmark.
Performance of James H Stanker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -20.65 | | | | | |
| Relative Return to S&P 500(%) | -19.52 | | | | | |
James H Stanker Ownership Network
Ownership Network List of James H Stanker
Ownership Network Relation of James H Stanker
James H Stanker Owned Company Details
What does Processa Pharmaceuticals Inc do?
Who are the key executives at Processa Pharmaceuticals Inc?
James H Stanker is the Chief Financial Officer of Processa Pharmaceuticals Inc. Other key executives at Processa Pharmaceuticals Inc include director & 10 percent owner & President & CEO David Young , Chief Business - Strategy Off Patrick Lin , and Chief Executive Officer George K Ng .
Processa Pharmaceuticals Inc (PCSA) Insider Trades Summary
Over the past 18 months, James H Stanker made no insider transaction in Processa Pharmaceuticals Inc (PCSA). Other recent insider transactions involving Processa Pharmaceuticals Inc (PCSA) include a net purchase of 81,000 shares made by David Young , a net purchase of 10,000 shares made by George K Ng , and a net purchase of 8,000 shares made by Justin W Yorke .
In summary, during the past 3 months, insiders sold 0 shares of Processa Pharmaceuticals Inc (PCSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Processa Pharmaceuticals Inc (PCSA) were sold and 65,000 shares were bought by its insiders, resulting in a net purchase of 65,000 shares.
Processa Pharmaceuticals Inc (PCSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Processa Pharmaceuticals Inc Insider Transactions
James H Stanker Mailing Address
Above is the net worth, insider trading, and ownership report for James H Stanker. You might contact James H Stanker via mailing address: 9008 Shadybrook Drive, Frederick Md 21701.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
